These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11418360)

  • 1. Dynamics of viral quasispecies during interferon therapy in non responder chronic hepatitis C patients.
    Thelu MA; Baud M; Leroy V; Seigneurin JM; Zarski JP
    J Clin Virol; 2001 Aug; 22(1):125-31. PubMed ID: 11418360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of serum hepatitis C virus load and quasispecies complexity during antiviral therapy in patients with chronic hepatitis C.
    Grahovac B; Bingulac-Popovic J; Vucelic B; Hrstic I; Ostojic R; Drazic V; Balija M; Grgicevic D
    J Clin Virol; 2001 Jan; 20(1-2):85-9. PubMed ID: 11163588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between diversity of hepatitis C virus quasispecies and viremia, activity of liver disease and response to interferon therapy].
    Tang X; Qian K; Yuan X; Johnson YN
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):128-31. PubMed ID: 12196822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of hepatitis C virus quasispecies heterogeneity by interferon-alpha and ribavirin therapy.
    González-Peralta RP; Liu WZ; Davis GL; Qian KP; Lau JY
    J Viral Hepat; 1997 Mar; 4(2):99-106. PubMed ID: 9097265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus quasispecies and response to interferon therapy in patients with chronic hepatitis C: a prospective study.
    Hino K; Yamaguchi Y; Fujiwara D; Katoh Y; Korenaga M; Okazaki M; Okuda M; Okita K
    J Viral Hepat; 2000 Jan; 7(1):36-42. PubMed ID: 10718941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypervariable region 1 of hepatitis C virus genome and response to interferon therapy.
    Grahovac B; Bingulac-Popović J; Vucelić B; Hrstić I; Ostojić R; Drazić V; Balija M; Grgicević D
    Clin Chem Lab Med; 2000 Sep; 38(9):905-10. PubMed ID: 11097348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
    Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
    J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of ribavirin on dynamics of hepatitis C viremia in interferon alpha-treated patiens with response or no response].
    Berg T; Kaul T; Naumann U; Wiedenmann B; Hopf U
    Z Gastroenterol; 2000 Nov; 38(11):881-6. PubMed ID: 11132533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon].
    López-Labrador FX; Ampurdanès S; Giménez-Barcons M; Guilera M; Costa J; Jiménez de Anta MT; Sánchez-Tapias JM; Rodés J; Sáiz JC
    Hepatology; 1999 Mar; 29(3):897-903. PubMed ID: 10051495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapy with interferon and ribavirin in chronic hepatitis C does not affect serum quasispecies diversity.
    Sookoian S; Castaño G; Frider B; Cello J; Campos R; Flichman D
    Dig Dis Sci; 2001 May; 46(5):1067-71. PubMed ID: 11341650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of hepatitis C virus quasispecies turnover during interferon-alpha treatment.
    von Wagner M; Lee JH; Rüster B; Kronenberger B; Sarrazin C; Roth WK; Zeuzem S
    J Viral Hepat; 2003 Nov; 10(6):413-22. PubMed ID: 14633173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of genetic variants of the 5' noncoding region of hepatitis C virus occurs only in patients responding to interferon alpha therapy.
    Lu M; Wiese M; Roggendorf M
    J Med Virol; 1999 Oct; 59(2):146-53. PubMed ID: 10459148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary structure of the hepatitis C virus 5' untranslated region and efficacy of interferon therapy for chronic hepatitis C.
    Suzuki K; Shinzawa H; Kuboki M; Ishibashi M; Yoshii E; Saito T; Takahashi T
    Liver; 1998 Oct; 18(5):331-6. PubMed ID: 9831362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C.
    González-Peralta RP; Qian K; She JY; Davis GL; Ohno T; Mizokami M; Lau JY
    J Med Virol; 1996 Jul; 49(3):242-7. PubMed ID: 8818972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy.
    Sandres K; Dubois M; Pasquier C; Payen JL; Alric L; Duffaut M; Vinel JP; Pascal JP; Puel J; Izopet J
    J Virol; 2000 Jan; 74(2):661-8. PubMed ID: 10623727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin.
    Abbate I; Lo Iacono O; Di Stefano R; Cappiello G; Girardi E; Longo R; Ferraro D; Antonucci G; Di Marco V; Solmone M; Craxì A; Ippolito G; Capobianchi MR
    J Hepatol; 2004 May; 40(5):831-6. PubMed ID: 15094232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep sequencing and phylogenetic analysis of variants resistant to interferon-based protease inhibitor therapy in chronic hepatitis induced by genotype 1b hepatitis C virus.
    Sato M; Maekawa S; Komatsu N; Tatsumi A; Miura M; Muraoka M; Suzuki Y; Amemiya F; Takano S; Fukasawa M; Nakayama Y; Yamaguchi T; Uetake T; Inoue T; Sato T; Sakamoto M; Yamashita A; Moriishi K; Enomoto N
    J Virol; 2015 Jun; 89(11):6105-16. PubMed ID: 25810555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy.
    Shindo M; Hamada K; Koya S; Arai K; Sokawa Y; Okuno T
    Hepatology; 1996 Nov; 24(5):1018-23. PubMed ID: 8903369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of increasing dose of interferon on the evolution of hepatitis C virus 1b quasispecies.
    De Mitri MS; Mele L; Morsica G; Chen CH; Sitia G; Gramenzi A; Andreone P; Alberti A; Bernardi M; Pisi E
    J Med Virol; 2000 Feb; 60(2):133-8. PubMed ID: 10596011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy.
    Moribe T; Hayashi N; Kanazawa Y; Mita E; Fusamoto H; Negi M; Kaneshige T; Igimi H; Kamada T; Uchida K
    Gastroenterology; 1995 Mar; 108(3):789-95. PubMed ID: 7533113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.